Whalegun
Home

Travere Therapeutics TVTX spent $175K on lobbying in Q3 2023 · Health Issues, Pharmacy and 4 more issues

Trade details

Type
Lobbying report
Amount
$175,000
Quarter
Q3 2023
Stock
Travere Therapeutics TVTX
Client
Travere Therapeutics
Reported
23/10/17

Up 9.4% from last quarter

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 23/08/31~23/10/30

Travere Therapeutics's other lobbying reports

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 08/04

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $70K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $140K

    Reported 07/20

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $16K

    Reported 05/19

  • Travere Therapeutics

    LobbyingTravere Therapeutics

    $80K

    Reported 04/20